Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria

Peroxisome proliferator-activated receptors (PPARs) alter the expression of genes involved in regulating lipid metabolism. Rosiglitazone, a PPARγ agonist, induces tissue-specific effects on lipid metabolism; however, its mode of action in skeletal muscle remains unclear. Since fatty acid translocase...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Benton, Carley R, Holloway, Graham P, Campbell, S E, Yoshida, Yuko, Tandon, Narendra N, Glatz, Jan F C, Luiken, Joost J J F P, Spriet, Lawrence L, Bonen, Arend
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2008
Konular:
Integrative
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375706/
https://ncbi.nlm.nih.gov/pubmed/18238811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1113/jphysiol.2007.146563
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller